Market Overview
The global spatial genomics & transcriptomics market is estimated to reach US$ XX million by 2029, growing at a CAGR of 9.35% during the forecast period (2022-2029).
Spatial transcriptomics is a ground-breaking molecular profiling technology that allows scientists to map all gene activity in a tissue sample and analyze it and spatial genomics is a new field of molecular biology that tries to examine the genomic information of single cells in their natural tissue context.
Market Dynamics
The spatial genomics and transcriptomics market will rise rapidly because of the emerging potential of spatial genomic analysis as a cancer diagnostic tool and the arrival of the fourth generation of sequencing.The spatial patterns of the genome have been recognized for treating various medical conditions, resulting in the use of spatial information as a diagnostic biomarker for a variety of diseases. There is a growing insistence on biomarkers, which allow for more accurate differentiation of benign tumours from malignant tumours, increasing the demand for spatial genomic analysis as a cancer diagnostic tool. As a result, the aggregate demand for robust cancer diagnostic solutions contributes to the overall market’s growth.
Technological advancements in sequencing technologies will boost market growth.
Key market participants are concentrating on expanding their spatial transcriptomics and genomics footprints through strategic partnerships and collaborations with other players. Furthermore, the companies are developing strategies to broaden their customer base worldwide. Dovetail Genomics, for example, announced the global availability of its Dovetail HiChIP and Micro-C Kits in February 2020.
Dovetail Micro-C kits provide better resolution of chromatin contacts at the mononucleosome level. In contrast, HiChIP technology combines the Micro-C and ChIP-seq technologies into a single workflow, allowing assaying protein-directed alterations to chromatin architecture and assessing their impact on gene expression.
Furthermore, rapid advances in fluorescence in-situ hybridization, microscopy-based live DNA imaging, and other biochemical techniques have aided the advancement of spatial genomics. Spatial genomics and transcriptomics are rapidly evolving research fields that aim to provide deeper insights into the cellular machinery, spatial organization, differentiation, and localization at the genomic and transcriptomics levels in tissues and cells. Spatial transcriptomics is a broad term used to describe methods for assigning cell types to specific locations across tissue samples. Spatial transcriptomics is a revolutionary technology that allows in-depth research into cell composition, physiology, and disease development. The increasing prevalence of chronic diseases such as aggressive cancers, cardiovascular disorders, neurological disorders, and malignant tumors has increased the demand for biomarker identification. It has simplified drug discovery and development processes to evaluate drug safety and efficacy even further. This is expected to drive demand for spatial transcriptomics technologies and market growth during the forecast period.
Download Sample Brochure @ https://www.datamintelligence.com/download-sample/spatial-genomics-and-transcriptomics-market
Market Segmentation
By Technique
- Spatial Transcriptomics
- Immunohistochemistry
- In Situ Hybridization
- Sequencing-Based Methods
By Application
- Translational Research
- Drug Discovery & Development
By Product Type
- Instruments
- Consumables
- Software
Competitive Landscape
The spatial genomics and transcriptomics market is fiercely competitive, with several main players. Few big firms currently dominate the market in terms of market share. Some of the key players which are contributing to the growth of the market include NanoString Technologies Inc, S2 Genomics Inc, Akoya Biosciences, ION path Inc, Fluidigm Corporation, 10X Genomics Inc, BioSpyder Technologies, Rebus Biosystems LLC, Resolve Biosciences, Vizgen Corporation. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the spatial genomics and transcriptomics market globally. For instance, in February 2020, ReadCoor, Inc. debuted its first product line, which includes the RC2 instrument and multi-omic spatial sequencing assays. To operate, the instrument uses the company’s Fluorescent In Situ Sequencing (FISSEQ) technology.
Trending Reports
DNA Methylation Sequencing Market
About Us:
DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision-making in designing disruptive solutions.
Media Contact:
Name: Sai Kiran
Company: DataM Intelligence
Contact No: +1 8774414866
Email us: info@datamintelligence.com